Since ROS1-positive tumours are very sensitive to treatment with tyrosine kinase inhibitors such as crizotinib, detecting this rare genetic alteration may be an important step in the diagnostic work-up of a patient with lung adenocarcinoma. The gene discussed is ROS1; the disease is lung adenocarcinoma.